Industry News
The CNIO discovers a link between a rare form of anemia and cancer
10/19/2015
Researchers from the Tumour Suppression Group at the Spanish National Cancer Research Centre (CNIO), headed by Manuel Serrano, have discovered the molecular mechanisms that determine cancer...
Antibody test could detect Alzheimer's at preventable stage
10/18/2015
A new test for antibodies could make it possible to detect Alzheimer's and other diseases at a stage early enough to preempt, delay or prevent them.
Antibody test could detect Alzheimer's at preventable stage
10/18/2015
A new test for antibodies could make it possible to detect Alzheimer's and other diseases at a stage early enough to preempt, delay or prevent them.
'Natural killer cells' breakthrough could 'double' the effect of a lifesaving cord blood transplant
10/16/2015
A research breakthrough by scientists at the blood cancer charity Anthony Nolan could lead to better outcomes for patients having stem cell transplants using umbilical cord blood.
Birmingham scientists find evidence of how incurable cancer develops
10/16/2015
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Phase II results show lenvatinib, when used in combination with everolimus, demonstrates significantly improved progression-free survival (PFS) versus everolimus alone in people with metastatic...
'Natural killer cells' breakthrough could 'double' the effect of a lifesaving cord blood transplant
10/16/2015
A research breakthrough by scientists at the blood cancer charity Anthony Nolan could lead to better outcomes for patients having stem cell transplants using umbilical cord blood.
Birmingham scientists find evidence of how incurable cancer develops
10/16/2015
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
FDA approves first focused ultrasound system for treating the prostate
10/16/2015
The US Food and Drug Administration has approved SonaCare Medical's Sonablate 450 focused ultrasound system for the ablation of prostate tissue.
FDA approves first focused ultrasound system for treating the prostate
10/16/2015
The US Food and Drug Administration has approved SonaCare Medical's Sonablate 450 focused ultrasound system for the ablation of prostate tissue.